Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00182923 · ClinicalTrials.gov registry record

Forearm Vascular Relaxation

A clinical trial, sponsored by National Institute on Aging (NIA).

Completed
Registry status
400
Enrollment target

NCT00182923: Completed study, sponsored by National Institute on Aging (NIA).

NCT00182923 is a clinical trial that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00182923 has completed, sponsored by National Institute on Aging (NIA).

COMPLETED
Registry status
400 participants
Enrollment target

Study Summary

The purpose of this study is to learn the effect of inherited differences on forearm blood flow responses to hormones and drugs

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2003-05
Est. Completion 2006-12
National Institute on Aging (NIA)

131 total trials

What the finished NCT00182923 record still lists

NCT00182923 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00182923 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00182923 about?

NCT00182923 is a clinical study titled "Forearm Vascular Relaxation". The purpose of this study is to learn the effect of inherited differences on forearm blood flow responses to hormones and drugs

What is the current status of trial NCT00182923?

This trial is currently completed. The enrollment target is 400 participants. The study started on 2003-05. Estimated completion is 2006-12.

Who is sponsoring clinical trial NCT00182923?

This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00182923, the US trial registry maintained by the National Library of Medicine. NCT00182923 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.